Zong Hai Li
Vorstandsvorsitzender bei CARSGEN THERAPEUTICS HOLDINGS LIMITED
Vermögen: 191 Mio $ am 31.05.2024
Profil
Zong Hai Li gründete CARsgen Therapeutics Holdings Ltd. und CARsgen Therapeutics Co. Ltd. Er ist Chairman, Chief Executive & Scientific Officer bei CARsgen Therapeutics Holdings Ltd. und President & Chief Executive Officer für CARsgen Therapeutics Co. Ltd. Dr. Li war zuvor als Professor am Shanghai Cancer Institute und als Professor am Renji Hospital tätig. Er erwarb einen Bachelor- und einen Master-Abschluss am Xiangya Hospital der Central South University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.06.2024 | 217 426 230 ( 37,77% ) | 191 Mio $ | 31.05.2024 |
Aktive Positionen von Zong Hai Li
| Unternehmen | Position | Beginn |
|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Vorstandsvorsitzender | 01.02.2021 |
CARsgen Therapeutics Co. Ltd.
 CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Vorstandsvorsitzender | 30.10.2014 |
Ehemalige bekannte Positionen von Zong Hai Li
| Unternehmen | Position | Ende |
|---|---|---|
Guilin Pavay Gene Pharmaceutical Co. Ltd.
 Guilin Pavay Gene Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hua Han Health Industry Holdings Ltd., Guilin Pavay Gene Pharmaceutical Co. Ltd. is a company that manufactures and distributes pharmaceutical products. The company is based in Guilin, China. | Corporate Officer/Principal | 01.04.2002 |
Shanghai Renji Hospital
 Shanghai Renji Hospital Hospital/Nursing ManagementHealth Services Shanghai Renji Hospital provides healthcare services. Shanghai Renji Hospital is based in Shanghai, China and was founded in 1844. The hospital is ultimately controlled by the Government of China. | Corporate Officer/Principal | - |
| The Shanghai Cancer Institute | Corporate Officer/Principal | - |
Ausbildung von Zong Hai Li
| Xiangya Hospital Central South University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CARsgen Therapeutics Co. Ltd.
CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Health Technology |
| The Shanghai Cancer Institute | |
Shanghai Renji Hospital
Shanghai Renji Hospital Hospital/Nursing ManagementHealth Services Shanghai Renji Hospital provides healthcare services. Shanghai Renji Hospital is based in Shanghai, China and was founded in 1844. The hospital is ultimately controlled by the Government of China. | Health Services |
Guilin Pavay Gene Pharmaceutical Co. Ltd.
Guilin Pavay Gene Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hua Han Health Industry Holdings Ltd., Guilin Pavay Gene Pharmaceutical Co. Ltd. is a company that manufactures and distributes pharmaceutical products. The company is based in Guilin, China. | Health Technology |
